Categories AlphaGraphs, Earnings, Health Care
AbbVie Q2 2024 adj. profit drops despite higher revenues; results beat
Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Thursday announced second-quarter 2024 financial results, reporting a decline in adjusted earnings and an increase in revenues. The numbers exceeded estimates.
The company reported worldwide net revenues of $14.46 billion for the June quarter, up 4.3% from the corresponding period of 2023 and above the market’s projection. All operating segments, except the Eye Care division, registered growth.
Net income, adjusted for special items, declined to $2.65 per share in Q2 from $2.91 per share in the year-ago quarter, but topped expectations. On a reported basis, second-quarter profit was $1.37 billion or $0.77 per share, compared to $2.02 billion or $1.14 per share last year.
Prior Performance
Most Popular
Will Nvidia (NVDA) continue recent winning streak in Q3 FY26?
Semiconductor giant Nvidia Corporation (NASDAQ: NVDA) is preparing to report third-quarter earnings, with investors watching closely for signs of sustained momentum in its data center business. It is estimated that
Lowe’s (LOW) Earnings Preview: Revenue and earnings anticipated to grow in Q3 2025
Shares of Lowe's Companies, Inc. (NYSE: LOW) were up 1% on Tuesday. The stock has dropped 3% in the past three months. The home improvement company is scheduled to report
Key metrics from Beyond Meat’s (BYND) Q3 2025 earnings results
Beyond Meat, Inc. (NASDAQ: BYND) reported its third quarter 2025 earnings results. Net revenues were $70.2 million, down 13.3% year-over-year. Net loss was $110.7 million, or $1.44 per share, compared
